Acadian Asset Management
PRAX icon

Acadian Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Acadian Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238K Buy
741
+112
+18% +$34.6K ﹤0.01% 1540
2025
Q4 		$184K Buy
+629
New +$117K ﹤0.01% 1534
2024
Q4 		– Sell
-1,189
Closed -$68K – 2049
2024
Q3 		$68K Buy
+1,189
New +$64.2K ﹤0.01% 1720
2024
Q2 		– Sell
-82,254
Closed -$5.02M – 1879
2024
Q1 		$5.02M Sell
82,254
-15,795
-16% -$709K 0.02% 466
2023
Q4 		$2.18M Buy
98,049
+2,417
+3% +$43.5K 0.01% 652
2023
Q3 		$2.45M Sell
95,632
-7,249
-7% -$137K 0.01% 635
2023
Q2 		$1.77M Buy
102,881
+9,787
+11% +$150K 0.01% 728
2023
Q1 		$1.13M Buy
93,094
+2,859
+3% +$121K ﹤0.01% 849
2022
Q4 		$3.22M Buy
90,235
+22,124
+32% +$690K 0.02% 555
2022
Q3 		$2.32M Buy
68,111
+12,837
+23% +$640K 0.01% 593
2022
Q2 		$2.03M Buy
+55,274
New +$5.9M 0.01% 628

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Acadian Asset Management's PRAX Position: Q1 2026 in Review

Acadian Asset Management increased its Praxis Precision Medicines (PRAX) stake by 18% in Q1 2026, buying an estimated $34.6K and bringing the position to 741 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #1540.

Acadian Asset Management first reported a position in PRAX in Q2 2022 and has held it in 11 quarters since. The position peaked at $5.02M in Q1 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Acadian Asset Management held 741 shares of Praxis Precision Medicines worth $238K as of Q1 2026.
  • Acadian Asset Management bought 112 Praxis Precision Medicines shares in Q1 2026, an estimated $34.6K.
  • Praxis Precision Medicines made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1540 holding.
  • Acadian Asset Management first reported a position in Praxis Precision Medicines in Q2 2022 and has held it in 11 quarters since.
  • Acadian Asset Management's Praxis Precision Medicines position peaked at $5.02M in Q1 2024.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.